All Pharma News
Gilead Announces Expiration of Waiting Period for CymaBay Tender Offer

Gilead Announces Expiration of Waiting Period for CymaBay Tender Offer
BUSINESSWIRE
11 Mar 2024
Share Share
CymaBay Announces EMA Accepts for Review the MAA for Seladelpar

CymaBay Announces EMA Accepts for Review the MAA for Seladelpar
GLOBENEWSWIRE
04 Mar 2024
Share Share
CymaBay Reports Fourth Quarter & Year Ended December 31, 2023 Financial Results

CymaBay Reports Fourth Quarter & Year Ended December 31, 2023 Financial Results
GLOBENEWSWIRE
28 Feb 2024
Share Share
CymaBay board pushed for 50 cent top up to Gilead`s $32.50 offer

CymaBay board pushed for 50 cent top up to Gilead`s $32.50 offer
Annalee Armstrong FIERCE BIOTECH
26 Feb 2024
Share Share
The New England Journal Publishes Positive Phase 3 of CymaBay`s Seladelpar

The New England Journal Publishes Positive Phase 3 of CymaBay`s Seladelpar
PR NEWSWIRE
21 Feb 2024
Share Share
CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GLOBENEWSWIRE
20 Feb 2024
Share Share
Cymabay Therapeutics Investor Alert By The Former Attorney General Of Louisiana

Cymabay Therapeutics Investor Alert By The Former Attorney General Of Louisiana
BUSINESSWIRE
16 Feb 2024
Share Share
Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics
PRESS RELEASE
13 Feb 2024
Share Share
CymaBay Announces FDA Acceptance of NDA and Priority Review for Seladelpar

CymaBay Announces FDA Acceptance of NDA and Priority Review for Seladelpar
PR NEWSWIRE
12 Feb 2024
Share Share
CymaBay Therapeutics to Participate in Upcoming Investment Conferences

CymaBay Therapeutics to Participate in Upcoming Investment Conferences
GLOBENEWSWIRE
31 Jan 2024
Share Share